UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 347

Sortiert nach

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions

BMC medical research methodology, 2021-03, Vol.21 (1), p.58-58, Article 58

2021

Volltextzugriff (PDF)

Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings

Addiction (Abingdon, England), 2019-06, Vol.114 (6), p.1026-1034

2019

Volltextzugriff (PDF)

Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study

PloS one, 2017-10, Vol.12 (10), p.e0184360-e0184360

2017

Volltextzugriff (PDF)

Polypharmacy among older Australians, 2006–2017: a population‐based study

Medical journal of Australia, 2019-07, Vol.211 (2), p.71-75

2019

Volltextzugriff (PDF)

Codeine use and harms in Australia: evaluating the effects of re‐scheduling

Addiction (Abingdon, England), 2020-03, Vol.115 (3), p.451-459

2020

Volltextzugriff (PDF)

An overview of the patterns of prescription opioid use, costs and related harms in Australia

British journal of clinical pharmacology, 2014-11, Vol.78 (5), p.1159-1166

2014

Volltextzugriff (PDF)

Twenty‐five years of prescription opioid use in Australia: a whole‐of‐population analysis using pharmaceutical claims

British journal of clinical pharmacology, 2016-07, Vol.82 (1), p.255-267

2016

Volltextzugriff (PDF)

A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data

Pharmacoepidemiology and drug safety, 2023-03, Vol.32 (3), p.352-365

2023

Volltextzugriff (PDF)

All‐cause and cause‐specific mortality in individuals with an alcohol‐related emergency or hospital inpatient presentation: A retrospective data linkage cohort study

Addiction (Abingdon, England), 2023-09, Vol.118 (9), p.1751-1762

2023

Volltextzugriff (PDF)

A national study on prescribed medicine use in Australia on a typical day

Pharmacoepidemiology and drug safety, 2020-09, Vol.29 (9), p.1046-1053

2020

Volltextzugriff (PDF)

Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship

British journal of clinical pharmacology, 2022-03, Vol.88 (3), p.1143-1151

2022

Volltextzugriff (PDF)

Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis

Anaesthesia, 2024-09, Vol.79 (9), p.967-977

2024

Volltextzugriff (PDF)

Predicting the risk of pancreatic cancer in women with new‐onset diabetes mellitus

Journal of gastroenterology and hepatology, 2024-06, Vol.39 (6), p.1057-1064

2024

Volltextzugriff (PDF)

Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations

International journal of cancer, 2022-01, Vol.150 (1), p.91-99

2022

Volltextzugriff (PDF)

Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality

Drug and alcohol review, 2023-09, Vol.42 (6), p.1461-1471

2023

Volltextzugriff (PDF)

Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population‐based case‐control study

Basic & clinical pharmacology & toxicology, 2020-10, Vol.127 (4), p.320-328

2020

Volltextzugriff (PDF)

A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1369-1377

2021

Volltextzugriff (PDF)

Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?

British journal of clinical pharmacology, 2023-11, Vol.89 (11), p.3411-3420

2023

Volltextzugriff (PDF)

Measuring Hospital-Acquired Complications Associated With Low-Value Care

JAMA internal medicine, 2019-04, Vol.179 (4), p.499

2019

Volltextzugriff (PDF)

Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis

Internal medicine journal, 2024-06, Vol.54 (6), p.941-950

2024

Volltextzugriff (PDF)

Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia

Diabetes, obesity & metabolism, 2024-07, Vol.26 (7), p.2787-2795

2024

Volltextzugriff (PDF)

Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia

British journal of clinical pharmacology, 2023-05, Vol.89 (5), p.1541-1553

2023

Volltextzugriff (PDF)

Long‐term trajectories of medicine use among older adults experiencing polypharmacy in Australia

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1264-1274

2021

Volltextzugriff (PDF)

Patterns of pregabalin initiation and discontinuation after its subsidy in Australia

British journal of clinical pharmacology, 2020-09, Vol.86 (9), p.1882-1887

2020

Volltextzugriff (PDF)

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children

Paediatric and perinatal epidemiology, 2022-09, Vol.36 (5), p.726-737

2022

Volltextzugriff (PDF)

1 – 25 von 347

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(342)
Mit Volltextzugriff
(320)

Publikationsform

Sprache

Englisch
(347)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(280)
Life Sciences & Biomedicine
(272)
Humans
(198)
Female
(124)
Australia
(101)
Male
(96)
Aged
(79)
Adult
(65)
Middle Aged
(65)
Oncology
(58)
Public, Environmental & Occupational Health
(58)
General & Internal Medicine
(56)
Medicine, General & Internal
(56)
Cancer
(52)
Health Care Sciences & Services
(52)
Pharmacoepidemiology
(49)
Aged, 80 And Over
(48)
Pharmacology & Pharmacy
(48)
Retrospective Studies
(41)
Australia - Epidemiology
(38)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Interrupted time series analysis using autoregressive integrated moving average (ARIMA) models: a guide for evaluating large-scale health interventions

Rising pregabalin use and misuse in Australia: trends in utilization and intentional poisonings

Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study

Polypharmacy among older Australians, 2006–2017: a population‐based study

Codeine use and harms in Australia: evaluating the effects of re‐scheduling

An overview of the patterns of prescription opioid use, costs and related harms in Australia

Twenty‐five years of prescription opioid use in Australia: a whole‐of‐population analysis using pharmaceutical claims

A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data

All‐cause and cause‐specific mortality in individuals with an alcohol‐related emergency or hospital inpatient presentation: A retrospective data linkage cohort study

A national study on prescribed medicine use in Australia on a typical day

Changes in antibiotic prescribing following COVID‐19 restrictions: Lessons for post‐pandemic antibiotic stewardship

Opioid analgesic exposure during the first trimester of pregnancy and the risk of major congenital malformations in infants: a systematic review and meta-analysis

Predicting the risk of pancreatic cancer in women with new‐onset diabetes mellitus

Resource stratified guidelines for cancer: Are they all the same? Interguideline concordance for systemic treatment recommendations

Mortality during and after specialist alcohol and other drug treatment: Variation in rates according to principal drug of concern and treatment modality

Risk of squamous cell carcinoma of the lip and cutaneous melanoma in older Australians using hydrochlorothiazide: A population‐based case‐control study

A cross sectional study of psychotropic medicine use in Australia in 2018: A focus on polypharmacy

Patterns of suboptimal antipsychotic use and misuse in Australia: What can routinely collected data tell us?

Measuring Hospital-Acquired Complications Associated With Low-Value Care

Quality use of publicly subsidised tapentadol in Australia: a population‐based analysis

Geographic variation in sodium‐glucose cotransporter 2 inhibitor and glucagon‐like peptide‐1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia

Potential drug–drug interactions due to concomitant medicine use among people living with HIV on antiretroviral therapy in Australia

Long‐term trajectories of medicine use among older adults experiencing polypharmacy in Australia

Patterns of pregabalin initiation and discontinuation after its subsidy in Australia

Prescribed medicine use and extent of off‐label use according to age in a nationwide sample of Australian children

Suchergebnisse filtern